VPN Plus+ ExclusiveStem cell therapies – leaping before looking?March 31, 2021By Brennen McKenzie, MA, MSc, VMD, cVMAAs often happens, preliminary research in laboratory animals and in human medicine led to relatively rapid commercialization and clinical use of stem cell treatments in veterinary medicine well before robust clinical trial evidence in companion animals with natural disease had been developed. Fortunately, as better evidence has been slowly accumulated, it is looking more and more like we may have “guessed right” in this case: the risks to our patients are minimal (though not negligible) and there may well be meaningful benefits.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
